Pittsburgh, PA
LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).
lygenesis.comThese are collections LyGenesis is a part of. Click on the collection name to view similar companies.
Series A
$19,000,000
Convertible Note
$11,000,000
Debt Financing
$4,000,000
Series A
$3,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on LyGenesis.